Brief: Eloxx Pharmaceuticals Reports Q2 Loss Per Share Of $0.20
06/08/2020 12:52
Aug 6 (Reuters) - Eloxx Pharmaceuticals Inc ELOX.O :
* ELOXX PHARMACEUTICALS REPORTS SECOND QUARTER 2020
FINANCIAL AND
OPERATING RESULTS AND PROVIDES BUSINESS UPDATE
* Q2 LOSS PER SHARE $0.20
* Q2 EARNINGS PER SHARE ESTIMATE $-0.21 -- REFINITIV IBES
DATA
* EXPECT CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES
WILL BE
SUFFICIENT TO FUND OPERATIONS THROUGH END OF 2021
Source text for Eikon: ID:nGNX7M77xv
Further company coverage: ELOX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eloxx Pharmaceuticals
See all newsNASDAQ RESUMED AT 02:24 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:19 PM
Brief: Eloxx Pharmaceuticals Provides ELX-02 And ZKN-013 Program Updates
Brief: Eloxx Pharmaceuticals Confirms That Alport Syndrome Patients Treated With Elx-02 In Phase 2 Study Had Improvement
Brief: Eloxx Pharmaceuticals Inc Reports Results In All Patients Treated With Elx-02 In Phase 2 Clinical Study For Alport Syndrome